Clinical Efficacy of HiPorfin Photodynamic Therapy for Advanced Obstructive Esophageal Cancer

Overview

Journal Technol Cancer Res Treat

Specialties Biomedical Engineering
Oncology
Pharmacology

Date 2020 Jun 25

PMID 32578508

Citations 6

Authors

Ruifang Zeng

Chen Liu

Libo Li

Xiaojun Cai

Run Chen

Zhiwen Li

Affiliations

Soon will be listed here.

Abstract

Objective: To explore the clinical efficacy of HiPorfin photodynamic therapy for advanced esophageal cancer and evaluate its impact on survival.

Methods: Retrospective analysis of 32 patients with advanced obstructive esophageal cancer at our institution from September 2013 to December 2016. HiPorfin was infused as the photosensitizer at a dose of 5 mg/kg, and after 48 hours, 630-nm laser irradiation was subsequently performed through an optical fiber that passed through the biopsy channel of a flexible endoscope.

Results: The effectiveness rate was 78.1% (25/32), and the significant efficacy rate was 56.3% (18/32). The dysphagia score decreased from 3.43 ± 0.73 to 1.79 ± 0.53 ( < .05). There was no grade 3 or more toxicity. The median overall survival was estimated to be 16 months. Univariate analysis showed higher overall survival with a Karnofsky Performance Status score ≥80 compared with a Karnofsky Performance Status score <80 (hazard ratio: 2.626; 95% CI: 1.091-6.322; = .024). Overall survival was higher in patients who had received radiation therapy than in patients who did not receive radiation therapy (hazard ratio: 3.574; 95% CI: 1.501-8.510; = .002).

Conclusion: Photodynamic therapy is an effective method for advanced esophageal cancer. The side effects are mild, and the short-term effect is good, especially in the relief of dysphagia. Photodynamic therapy can prolong the survival of patients with advanced esophageal cancer, and the Karnofsky Performance Status score and previous radiation therapy have a significant effect on the overall survival.

Citing Articles

Hiporfin-photodynamic therapy for high-grade squamous intraepithelial lesions of the endocervical canal in young women.

Liu Y, Li R, Li C, Shang J, Wei L, Wu R Sci Rep. 2024; 14(1):28423.

PMID: 39558016 PMC: 11574053. DOI: 10.1038/s41598-024-79980-1.

Photodynamic therapy compared with loop electrosurgical excision procedure in patients with cervical high-grade squamous intraepithelial lesion.

Liu Y, Li R, Li C, Liu Z, Duan L, Huang Q Sci Rep. 2024; 14(1):27090.

PMID: 39511389 PMC: 11543842. DOI: 10.1038/s41598-024-78445-9.

Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studies.

Zhao W, Wang L, Zhang M, Liu Z, Wu C, Pan X MedComm (2020). 2024; 5(7):e603.

PMID: 38911063 PMC: 11193138. DOI: 10.1002/mco2.603.

HiPorfin photodynamic therapy for vaginal high-grade squamous intraepithelial lesion.

Liu Y, Wu R, Li C, Duan L, Wei L, Li R Arch Gynecol Obstet. 2024; 310(2):1197-1205.

PMID: 38900194 PMC: 11258174. DOI: 10.1007/s00404-024-07600-4.

Photodynamic therapy improves the clinical efficacy of advanced colorectal cancer and recruits immune cells into the tumor immune microenvironment.

Gu B, Wang B, Li X, Feng Z, Ma C, Gao L Front Immunol. 2022; 13:1050421.

PMID: 36466825 PMC: 9716470. DOI: 10.3389/fimmu.2022.1050421.

References

MCCAUGHAN Jr J, Ellison E, Guy J, Hicks W, Jones J, Laufman L . Photodynamic therapy for esophageal malignancy: a prospective twelve-year study. Ann Thorac Surg. 1996; 62(4):1005-9; discussion 1009-10. DOI: 10.1016/0003-4975(96)00563-2. View

Lindenmann J, Matzi V, Neuboeck N, Anegg U, Baumgartner E, Maier A . Individualized, multimodal palliative treatment of inoperable esophageal cancer: clinical impact of photodynamic therapy resulting in prolonged survival. Lasers Surg Med. 2012; 44(3):189-98. DOI: 10.1002/lsm.22006. View

Luketich J, Christie N, Buenaventura P, Weigel T, Keenan R, Nguyen N . Endoscopic photodynamic therapy for obstructing esophageal cancer: 77 cases over a 2-year period. Surg Endosc. 2000; 14(7):653-7. DOI: 10.1007/s004640000144. View

Mimura S, Narahara H, Hirashima T, Fukutomi H, Nakahara A, Kashimura H . Cooperative Clinical Trial of Photodynamic Therapy for Early Gastric Cancer With Photofrin Injection and YAG-OPO Laser. Diagn Ther Endosc. 2008; 4(4):165-71. PMC: 2362606. DOI: 10.1155/DTE.4.165. View

Li L, Xie J, Zhang X, Chen J, Luo Y, Zhang L . Retrospective study of photodynamic therapy vs photodynamic therapy combined with chemotherapy and chemotherapy alone on advanced esophageal cancer. Photodiagnosis Photodyn Ther. 2010; 7(3):139-43. DOI: 10.1016/j.pdpdt.2010.06.002. View

Tanaka T, Matono S, Nagano T, Murata K, Sueyoshi S, Yamana H . Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus. Gastrointest Endosc. 2010; 73(1):1-6. DOI: 10.1016/j.gie.2010.08.049. View

Yano T, Muto M, Hattori S, Minashi K, Onozawa M, Nihei K . Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy. 2008; 40(9):717-21. DOI: 10.1055/s-2008-1077480. View

Huang Z . An update on the regulatory status of PDT photosensitizers in China. Photodiagnosis Photodyn Ther. 2009; 5(4):285-7. DOI: 10.1016/j.pdpdt.2009.01.005. View

Gahlen J, Prosst R, Stern J . [Photodynamic therapy in the gastrointestinal tract. Possibilities and limits]. Chirurg. 2002; 73(2):122-31. DOI: 10.1007/s00104-001-0371-7. View

10.

Cheon Y, Kim W, Cho J, Lee J, Lee M, Shim C . Outcome of photodynamic therapy for early esophageal cancer. Gut Liver. 2010; 1(2):126-31. PMC: 2871623. DOI: 10.5009/gnl.2007.1.2.126. View

11.

Yano T, Muto M, Yoshimura K, Niimi M, Ezoe Y, Yoda Y . Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer. Radiat Oncol. 2012; 7:113. PMC: 3410784. DOI: 10.1186/1748-717X-7-113. View

12.

Jin M, Yang B, Zhang W, Ren P . Evaluation of photodynamic therapy in advanced gastrointestinal cancer. J Clin Laser Med Surg. 1991; 9(1):45-8. DOI: 10.1089/clm.1991.9.45. View

13.

Huang Z, Xu H, Meyers A, Musani A, Wang L, Tagg R . Photodynamic therapy for treatment of solid tumors--potential and technical challenges. Technol Cancer Res Treat. 2008; 7(4):309-20. PMC: 2593637. DOI: 10.1177/153303460800700405. View

14.

Yoon H, Cheon Y, Choi H, Shim C . Role of photodynamic therapy in the palliation of obstructing esophageal cancer. Korean J Intern Med. 2012; 27(3):278-84. PMC: 3443720. DOI: 10.3904/kjim.2012.27.3.278. View

15.

Chang Y, Lee J, Ko W, Lee Y . Airway obstruction following bronchoscopic photodynamic therapy in early centrally located lung cancer requiring extracorporeal membrane oxygenation. J Formos Med Assoc. 2013; 112(1):54-6. DOI: 10.1016/j.jfma.2012.07.013. View

16.

Saczko J, Chwilkowska A, Kulbacka J, Berdowska I, Zielinski B, Drag-Zalesinska M . Photooxidative action in cancer and normal cells induced by the use of photofrin in photodynamic therapy. Folia Biol (Praha). 2008; 54(1):24-9. View

17.

Rogers L, Sergeeva N, Paszko E, Vaz G, Senge M . Lead Structures for Applications in Photodynamic Therapy. 6. Temoporfin Anti-Inflammatory Conjugates to Target the Tumor Microenvironment for In Vitro PDT. PLoS One. 2015; 10(5):e0125372. PMC: 4437655. DOI: 10.1371/journal.pone.0125372. View

18.

Litle V, Luketich J, Christie N, Buenaventura P, Alvelo-Rivera M, McCaughan J . Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. Ann Thorac Surg. 2003; 76(5):1687-92. DOI: 10.1016/s0003-4975(03)01299-2. View

19.

Hatogai K, Yano T, Kojima T, Onozawa M, Daiko H, Nomura S . Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Gastrointest Endosc. 2015; 83(6):1130-1139.e3. DOI: 10.1016/j.gie.2015.11.016. View

20.

Pennathur A, Gibson M, Jobe B, Luketich J . Oesophageal carcinoma. Lancet. 2013; 381(9864):400-12. DOI: 10.1016/S0140-6736(12)60643-6. View